Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 80

Similar articles for PubMed (Select 20019322)

1.

Estimating the risks and benefits of nicotine replacement therapy for smoking cessation in the United States.

Apelberg BJ, Onicescu G, Avila-Tang E, Samet JM.

Am J Public Health. 2010 Feb;100(2):341-8. doi: 10.2105/AJPH.2008.147223. Epub 2009 Dec 17.

2.

Modelling the health benefits of smoking cessation in Japan.

Avila-Tang E, Apelberg BJ, Yamaguchi N, Katanoda K, Sobue T, Samet JM.

Tob Control. 2009 Feb;18(1):10-7. doi: 10.1136/tc.2007.024620. Epub 2008 Aug 26. Review.

3.

Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece.

Athanasakis K, Igoumenidis M, Karampli E, Vitsou E, Sykara G, Kyriopoulos J.

Clin Ther. 2012 Aug;34(8):1803-14. doi: 10.1016/j.clinthera.2012.07.002. Epub 2012 Jul 20.

PMID:
22818870
4.

'Cut down to quit' with nicotine replacement therapies in smoking cessation: a systematic review of effectiveness and economic analysis.

Wang D, Connock M, Barton P, Fry-Smith A, Aveyard P, Moore D.

Health Technol Assess. 2008 Feb;12(2):iii-iv, ix-xi, 1-135. Review.

5.

[Smoking reduction and temporary abstinence: new approaches for smoking cessation].

Le Houezec J, Säwe U.

J Mal Vasc. 2003 Dec;28(5):293-300. Review. French.

PMID:
14978435
6.

Over-the-counter availability of nicotine replacement therapy and smoking cessation.

Hyland A, Rezaishiraz H, Giovino G, Bauer JE, Michael Cummings K.

Nicotine Tob Res. 2005 Aug;7(4):547-55. Erratum in: Nicotine Tob Res. 2010 Nov;12(11):1180.

PMID:
16085526
7.

Cost effectiveness of varenicline in Belgium, compared with bupropion, nicotine replacement therapy, brief counselling and unaided smoking cessation: a BENESCO Markov cost-effectiveness analysis.

Annemans L, Nackaerts K, Bartsch P, Prignot J, Marbaix S.

Clin Drug Investig. 2009;29(10):655-65. doi: 10.2165/11317730-000000000-00000.

PMID:
19715382
8.

Cost analysis of varenicline versus bupropion, nicotine replacement therapy, and unaided cessation in Nicaragua.

Lutz MA, Lovato P, Cuesta G.

Hosp Pract (1995). 2012 Feb;40(1):35-43. doi: 10.3810/hp.2012.02.946.

PMID:
22406881
9.

Nicotine replacement: a new approach to reducing tobacco-related harm.

Jiménez-Ruiz C, Kunze M, Fagerström KO.

Eur Respir J. 1998 Feb;11(2):473-9. Review.

11.
12.
13.

[Nicotine replacement therapy versus gradual smoking withdrawal in smoking cessation].

Marcos T, Godás T, Corominas J.

Med Clin (Barc). 2004 Jun 26;123(4):127-30. Spanish.

PMID:
15274804
14.

Use of nicotine replacement therapy for smoking reduction and during enforced temporary abstinence: a national survey of English smokers.

Beard E, McNeill A, Aveyard P, Fidler J, Michie S, West R.

Addiction. 2011 Jan;106(1):197-204. doi: 10.1111/j.1360-0443.2010.03215.x. Epub 2010 Nov 18.

PMID:
21083833
15.

The benefits and risks of over-the-counter availability of nicotine polacrilex ("nicotine gum").

Oster G, Delea TE, Huse DM, Regan MM, Colditz GA.

Med Care. 1996 May;34(5):389-402.

PMID:
8614162
16.

Relapse prevention in UK Stop Smoking Services: current practice, systematic reviews of effectiveness and cost-effectiveness analysis.

Coleman T, Agboola S, Leonardi-Bee J, Taylor M, McEwen A, McNeill A.

Health Technol Assess. 2010 Oct;14(49):1-152, iii-iv. doi: 10.3310/hta14490. Review.

17.
18.

Nicotine replacement therapy: perceptions of African-American smokers seeking to quit.

Yerger VB, Wertz M, McGruder C, Froelicher ES, Malone RE.

J Natl Med Assoc. 2008 Feb;100(2):230-6.

PMID:
18300540
19.

Does over-the-counter nicotine replacement therapy improve smokers' life expectancy?

Lawrence WF, Smith SS, Baker TB, Fiore MC.

Tob Control. 1998 Winter;7(4):364-8.

20.

Public health benefit of over-the-counter nicotine medications.

Shiffman S, Gitchell J, Pinney JM, Burton SL, Kemper KE, Lara EA.

Tob Control. 1997 Winter;6(4):306-10.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk